- 1 How do you get referred to St Jude?
- 2 What type of patients does St Jude treat?
- 3 Does St Jude really not charge patients?
- 4 How many patients are treated at St Jude?
- 5 Is St. Jude’s a good charity?
- 6 How much does it cost to run St. Jude’s Hospital for one day?
- 7 What is the survival rate at St Judes hospital?
How do you get referred to St Jude?
You can contact the Physician / Patient Referral Office or St. Contact St. Jude
- Call: 1-888-226-4343 (toll-free) or 901-595-4055. After hours, please feel free to leave a voice mail and the call will be returned the next business day.
- Email: [email protected]
- Emergencies: page us at 1-800-349-4334.
What type of patients does St Jude treat?
St. Jude treats children with cancer, blood disorders and related life-threatening diseases. We take the toughest cases. This often includes children who do not respond well to standard treatments.
Does St Jude really not charge patients?
Jude Children’s Research Hospital, founded in 1962, is a pediatric treatment and research facility focused on children’s catastrophic diseases, particularly leukemia and other cancers. The hospital costs about US$2.8 million a day to run, but patients are not charged for their care.
How many patients are treated at St Jude?
St. Jude sees more than 7,800 active patients each year and provides hundreds of free consultations for doctors worldwide. St. Jude conducts more clinical trials for cancer than any other children’s hospital across the U.S.
Is St. Jude’s a good charity?
Jude charity rating and review. According to Charity Navigator, ALSAC/St. Jude Children’s Research Hospital has a four-out-of-four star rating for our Overall Score and Rating.
How much does it cost to run St. Jude’s Hospital for one day?
The daily operating cost of St. Jude is $2.2 million.
What is the survival rate at St Judes hospital?
St. Jude patients with acute lymphoblastic leukemia have a 94 percent survival rate, the best worldwide outcomes for that disease. St. Jude was the first hospital in the U.S. to remove cranial irradiation from treatment for ALL while maintaining excellent survival rates.